BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28566248)

  • 21. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reirradiation of recurrent head and neck cancers with curative intent.
    Chmura SJ; Milano MT; Haraf DJ
    Semin Oncol; 2004 Dec; 31(6):816-21. PubMed ID: 15599860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
    Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stereotactic irradiation in head and neck cancers].
    Benhaïm C; Lapeyre M; Thariat J
    Cancer Radiother; 2014; 18(4):280-96. PubMed ID: 25059767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
    Alterio D; Zaffaroni M; Bossi P; Dionisi F; Elicin O; Falzone A; Ferrari A; Jereczek-Fossa BA; Sanguineti G; Szturz P; Volpe S; Scricciolo M
    Radiol Med; 2024 Jan; 129(1):160-173. PubMed ID: 37731151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
    Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.
    Martínez-Fernández MI; Alcalde J; Cambeiro M; Peydró GV; Martínez-Monge R
    Radiother Oncol; 2017 Feb; 122(2):255-259. PubMed ID: 27745912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
    Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
    J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.
    Pollard C; Nguyen TP; Ng SP; Frank SJ; Garden AS; Gunn GB; Fuller CD; Beadle BM; Morrison WH; Shah SJ; Wang H; Tung S; Wang C; Ginsberg LD; Zafereo ME; Sturgis EM; Su SY; Hanna EY; Rosenthal DI; Phan J
    Head Neck; 2017 Oct; 39(10):2079-2087. PubMed ID: 28741749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Bots WTC; van den Bosch S; Zwijnenburg EM; Dijkema T; van den Broek GB; Weijs WLJ; Verhoef LCG; Kaanders JHAM
    Head Neck; 2017 Jun; 39(6):1122-1130. PubMed ID: 28263446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and quality-of-life outcomes after reirradiation for head and neck cancer.
    Chen AM; Vazquez E; Michaud AL; Farwell DG; Purdy JA
    Laryngoscope; 2014 Aug; 124(8):1807-12. PubMed ID: 24338219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
    Cohen EE; Rosine D; Haraf DJ; Loh E; Shen L; Lusinchi A; Vokes EE; Bourhis J
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):678-84. PubMed ID: 17293229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
    Rusthoven KE; Feigenberg SJ; Raben D; Kane M; Song JI; Nicolaou N; Mehra R; Burtness B; Ridge J; Swing R; Lango M; Cohen R; Jimeno A; Chen C
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1020-5. PubMed ID: 20231078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
    Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reirradiation for recurrent head and neck carcinoma.
    Peponi E; Balta S; Tasiou I; Gogou P; Capizzello A; Pitouli E; Tsekeris P
    J BUON; 2012; 17(3):465-70. PubMed ID: 23033283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reirradiation in head and neck cancers.
    Janot F; Thariat J; Daly-Schweitzer N
    Anticancer Drugs; 2011 Aug; 22(7):634-8. PubMed ID: 21270718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
    Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer.
    Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Gagnon GJ; Hwang J; Slack RS; Noone AM; Harter KW
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1411-9. PubMed ID: 20056341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reirradiation and re-reirradiation in head-and-neck cancers: Learnings based on a case irradiated six times.
    Singh D; Goel A; Chaudhary P; Subramaniam B
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S467-S470. PubMed ID: 36511006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
    Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
    Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.